| 产品详情 |
| Edit |   |
|---|
| Product Name | FASN Human, Control Peptide (Fatty Acid Synthase) |
|---|
| Description | Purified. Fatty Acid Synthase (FASN) catalyzes the synthesis of palmitate from acetyl-CoA and malonyl-CoA, in the presence of NADPH, into long-chain saturated fatty acids. In some cancer cell lines, this protein has been found to be fused with estrogen receptor-alpha (ER-alpha), in which the N-terminal of FASN is fused in-frame with the C-terminal of ER-alpha. FASN is highly expressed in adipocytes and liver. FASN is a central enzyme in de novo lipogenesis. FASN is a target for SREBP and is upregulated by LXR activation; it is also one of the accepted markers for insulin resistance, SREBP and LXR activation. FASN: Bovine: 2513aa; Pig: 2411aa; Chick: 2511aa; Mouse: 2504aa; Rat: 2505aa; Human: 2511aa; 273.4kD; 17q25. Expression: Ubiquitous; more prominent expression in brain, lungs, and liver. Source: Synthetic peptide corresponding to 18aa of ~N-termial of human FASN (KLH) (P49327). Applications: Suitable for use in ELISA and Antibody Blocking. |
|---|
| Size | 100ug |
|---|
| Concentration | n/a |
|---|
| Applications | ELISA |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | SwissProt: P49327 |
|---|
| Catalog # | F0020-12 |
|---|
| Price | |
|---|
| Order / More Info | FASN Human, Control Peptide (Fatty Acid Synthase) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|